Who can use Agamree(Vamorolone)?
It is indicated for the treatment of Duchenne Muscular Dystrophy (DMD) in patients aged 2 years and older.
Vamorolone(Agamree)
Duchenne muscular dystrophy (DMD) in patients aged 2 years and older.
CATEGORY NAVIGATION
RELATED ARTICLES
FDA approves Agamree (vamorolone) for the treatment of Duchenne muscular dystrophy
Agamree (vamorolone) is the first differentiated glucocorticoid drug approved by the US FDA, designed for patients...
Friday, July 18th, 2025, 13:56
Agamree's International approval and price information
Agamree (vamoxone) is the first innovative glucocorticoid approved for the treatment of Duchenne muscular dystrophy...
Friday, July 18th, 2025, 13:51
2 / 2
5 in total
Departments
Contact Medical Consultant
Global Drug
Search
Clinical
recruitment
overseas
medical treatment
Remote
consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly
protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved